INNOVATIVE SOLUTIONS
FOR INHALATION
SAFETY

In vitro specialists for immune responses in the lung

ImmuONE delivers innovative respiratory in vitro cell culture products and services focusing on innate immune responses

IN VITRO INNOVATION SERVICES FOR EMPOWERED DECISION MAKING

ImmuONE provides innovative respiratory in vitro cell culture products and contract research services for inhalation safety testing. Our focus is supporting companies and researchers to understand the interaction and safety implications of inhaled products with immune cells in the airways.

We use state-of-the-art techniques within our in-house service portfolio to address unmet needs within inhalation assessment. Our specialist team of in vitro scientists work closely with customers to develop assays and strategies that solve your toxicity and translational needs.

Generating human-relevant results with multiple endpoints

Standard portfolio

Standard portfolio

Our contract research services with leading experts provide a tailored experimental design to directly address your in vitro inhalation assessment needs

Advanced multi-metric assessments

Advanced multi-metric assessments

We use state-of-the-art high content imaging techniques to combine multiple endpoints for immune cells which support mechanistic understanding and can directly translate to clinical studies

Novel immune-competent products

Novel immune-competent products

Our patented products ImmuPHAGE™ and ImmuLUNG™ provide a detailed understanding of the immune response in the lungs to inhaled chemicals and products

Importance of airway immune responses for inhaled products

Along with the air we inhale, each breath also contains a cocktail of chemicals and particles from our environment. The immune system in the lungs interacts with these chemicals and determines the body’s response to them. Despite respiratory immunology being a key aspect of inhaled product safety, in vitro models and assays to mimic these responses was an unmet need and animal experiments have traditionally been heavily relied upon to provide this information.

Since 2013, researchers at ImmuONE have been working to provides a solution to this problem.

We are experts in the lung’s immune system – in particular, the alveolar macrophages which are the first to respond when a chemical enters the respiratory system. Our services, products and experts enable you to understand, in detail how alveolar macrophages respond to inhaled chemicals/particulates and support classification of the response as being adaptive or adverse.

Our unique in vitro models and multi-endpoint assessments deliver results spanning morphology, function and biochemistry to provide companies with clarity on the human health impact of their products. We provide a a cost-effective, multi-endpoint alternative which is more human-relevant and reduces animal testing, exploring various interpretations of a read-out.
We carry out a wide variety of in vitro services in-house, with a specialisation in alveolar cell painting assays. Our morph_ONETM assay combines detailed cell morphology with cell health and biochemical readouts to help classify the mechanism of ‘foamy’, highly vacuolated macrophages to support safety assessment. Our two novel products – ImmuPHAGE™ and ImmuLUNG™ – provide in-depth analysis of macrophage responses in the lungs and epithelial tissue of the alveoli.

Importance of airway immune responses for inhaled products

Historically, alveolar safety has relied on epithelial cell models, which, though convenient, offer a narrow scope—primarily focusing on barrier function or cytotoxicity. Such limited endpoints may overlook potential long-term adverse effects on lung health, especially concerning inflammation from chronic product administration. The lung’s first responders, alveolar macrophages, play a pivotal role in homeostasis and regulating inflammation. Inflammation is not only a marker of acute reactions but also indicative of long-term health implications in the respiratory tract. Therefore, to ensure the comprehensive safety of inhaled products, it’s imperative to employ immune-competent models that capture the nuanced responses of alveolar macrophages. Only through understanding these responses can we truly gauge the safety and potential inflammatory impact of inhaled substances.

Our services, products and experts enable you to understand, in detail, how alveolar macrophages respond to inhaled chemicals/particulates and support classification of the response as being adaptive or adverse.

Our unique in vitro models and multi-endpoint assessments deliver results spanning morphology, function and biochemistry to provide companies with clarity on the human health impact of their products. We provide a cost-effective, multi-endpoint alternative which is more human-relevant and reduces animal testing, exploring various interpretations of a read-out.

We carry out a wide variety of in vitro services in-house, with a specialisation in alveolar high content imaging assays. Our morph_ONE™ assay combines detailed cell morphology with cell health and biochemical readouts to help classify the mechanism of ‘foamy’, highly vacuolated macrophages to support safety assessment. Our two novel products – ImmuPHAGE™ and ImmuLUNG™ – provide in-depth analysis of macrophage responses in the lungs and epithelial tissue of the alveoli.

IMPORTANCE OF AIRWAY IMMUNE RESPONSES

Understanding the inflammatory response of the airways to inhaled substances is paramount to assessing the long-term adverse effects on lung health. Many inhaled substances reach the small or distal airways, and it is in this region of the lung where alveolar macrophages are the first responders to these substances and play a pivotal role in homeostasis and regulating inflammation. Therefore, to ensure a comprehensive safety of inhaled products, it’s imperative to employ immune-competent models that capture the nuanced responses of alveolar macrophages.

At ImmuONE, we specialise in alveolar macrophage models and responses. Our services, products and experts enable you to understand, in detail how alveolar macrophages respond to inhaled chemicals/particulates and support classification of the response as being adaptive or adverse.

The advantages of in vitro

Applications

Therapeutics

Consumer Goods

Pharma Discovery

Chemicals

Cosmetics

Crop Protection

Environment

For more information

Email us at info@immuone.com

News Articles

That’s a wrap for 2023!

New innovations, new research, new teammates, a new lab – and soon, a new year! Before we turn our attention to 2024, let’s take a step back and appreciate all we’ve achieved so far.

Highlights from ImmuONE’s  First Webinar  

ImmuONE made a significant stride on November 8th by hosting its first-ever webinar, ‘unveiling insights into the next generation of tools for inhalation risk assessment’. The webinar began with a glimpse into ImmuONE’s evolution, emphasizing key milestones and leadership perspectives, presented by Prof. Victoria Hutter.

Scroll to Top